This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

223 result(s)

GSKpro for UK healthcare professionals

A portal for UK healthcare professionals containing GSK product information, patient resources, exclusive webinars and more

Ordering and delivery

Find out how to set up an account and start ordering GSK vaccines.

DECTOVA▼

zanamivir IV</br> Influenza

Contact | GSKpro UK

GSK UK contact page for healthcare professionals.

Report a possible side effect | GSKpro

Information for UK healthcare professionals on how to report an adverse event related to a GSK product

Request a contact

Contact us form for UK healthcare professionals to contact GSK

Therapy areas | GSKpro UK

Learn about GSK’s product portfolio in respiratory, vaccines, oncology and more. This page is for UK healthcare professionals only.

VENTOLIN

salbutamol<br>Respiratory

FLIXOTIDE

fluticasone propionate<br>Respiratory

BLENREP▼

belantamab mafodotin<br> Oncology

Ellipta critical error studies in COPD

Information about the benefits of GSK's Ellipta inhaler for UK healthcare professionals to support their COPD patients

XEVUDY ▼ (sotrovimab)

XEVUDY▼ (sotrovimab) label information for patients and healthcare professionals in Great Britain, including summary of product characteristics and patient information leaflet.

Coming soon | GSKpro

This page is under construction. If you require assistance, please connect with our Customer Support team via live chat or request to be contacted by a suitable GSK contact.

Respiratory

Overview of COPD and severe asthma.

Vaccines

GSK UK information about our vaccines

GSKpro Home | SHINGRIX

SHINGRIX information for UK healthcare professionals only

Immunocompromised | SHINGRIX

SHINGRIX information for UK healthcare professionals only

Immunocompromised Clinical Data | SHINGRIX

SHINGRIX information for UK healthcare professionals only

GSKpro Implementation | SHINGRIX

SHINGRIX information for UK healthcare professionals only

GSKpro Impact of Shingles | SHINGRIX

SHINGRIX information for UK healthcare professionals only

GSKpro SHINGRIX overview | SHINGRIX

SHINGRIX information for UK healthcare professionals only

GSKpro Efficacy | SHINGRIX

SHINGRIX information for UK healthcare professionals only

GSKpro Safety | SHINGRIX

SHINGRIX information for UK healthcare professionals only

Discontinued products | GSK Pro

Discontinued products

Therapy areas | GSKpro UK

Learn about GSK’s product portfolio in respiratory, vaccines, oncology and more. This page is for UK healthcare professionals only.

AREXVY▼

Respiratory Syncytial Virus Vaccine, Adjuvanted<br>Vaccines

OMJJARA▼

momelotinib<br>Oncology

Products | GSKpro

GSK product information for UK healthcare professionals

ZEJULA

niraparib<br>Oncology

Get in touch | OMJJARA▼ (momelotinib) UK

OMJJARA▼ (momelotinib) UK | Get in touch | This page contains promotional information about OMJJARA▼ (momelotinib). For UK Healthcare professionals only

GSKpro Arexvy ▼ | Product Information for Healthcare Professionals

AREXVY information for UK Healthcare professionals only

ZEJULA (niraparib)

Overview of ZEJULA (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only

Efficacy | ZEJULA (niraparib)

The efficacy data for ZEJULA (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only

PRIMA Study design

The PRIMA study design for ZEJULA (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only

PRIME Study design

PRIME study design for ZEJULA (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only

PRIMA PFS

The efficacy data for ZEJULA (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only

PRIME PFS

The PRIME Study efficacy data for ZEJULA (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only

PRIMA Overview

The safety profile and adverse events of ZEJULA (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only

Safety Profile | ZEJULA (niraparib)

The safety profile and adverse events of ZEJULA (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only

PRIMA Reported TEAE's

The safety profile and adverse events of ZEJULA (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only

PRIME study overview

The safety profile and adverse events of ZEJULA (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only

PRIMA Safety profile

The safety profile and adverse events of ZEJULA (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only

Zejula Required Monitoring

The safety profile and adverse events of ZEJULA (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only

PRIME Reported TEAE's

The safety profile and adverse events of ZEJULA (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only

PRIME Safety profile

The safety profile and adverse events of ZEJULA (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only

Quality of life | ZEJULA (niraparib)

Quality of life data about ZEJULA (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only

QoL

Quality of life data about ZEJULA (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only

QoL

Recommended dosing

Recommended dosing for ZEJULA (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only

Dosing | ZEJULA (niraparib)

Individualised starting dose for ZEJULA (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only

Dosing | ZEJULA (niraparib)

Recommended dosing for ZEJULA (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only

MoA

ZEJULA (niraparib) MoA

Overview of the mechanism of action for ZEJULA (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only

Webinars & events | GSKpro

A collection of promotional events and webinars featuring experts for UK healthcare professionals

Supply

Information to be provided to Healthcare Professionals on GSK’s medicines and vaccines supply availability

Resources | GSKpro

Support your patients and practice with these healthcare resources, ranging from training devices to patient support information.

No results. Why not try:

  • Checking the spelling of the search term
  • Trying a different search term
  • Resetting or revising the filter settings (if you used filters to do this search)

Show more